Form 4: Phreesia Inc. Director Michael Weintraub Reports Stock Transactions
SEC Form 4 Filing
Director Michael Weintraub reports acquisition of restricted stock units and indirect ownership of Phreesia, Inc. shares through trusts.
Summary
- On June 26, 2024, Michael Weintraub, a director of Phreesia, Inc., acquired 8,490 restricted stock units (RSUs) under the company's 2019 Stock Option and Incentive Plan.
- These RSUs will vest in full upon the earlier of June 26, 2025, or the next annual meeting of Phreesia's stockholders.
- Weintraub also indirectly owns 144,845 shares through a 2023 Qualified Annuity Trust and 6,703 shares through the Weintraub Family 2017 Irrevocable Trust.
- Weintraub disclaims beneficial ownership of the shares held in the trusts except to the extent of his pecuniary interest.
Sentiment
Score: 6
Explanation: Neutral sentiment. The filing is a standard disclosure of stock transactions by a company director. The acquisition of RSUs is a positive sign, but it's a routine part of executive compensation.
Positives
- The acquisition of RSUs by a director signals confidence in the company's future performance.
Future Outlook
The vesting of the RSUs is contingent upon continued service until June 26, 2025, or the next annual meeting, aligning the director's interests with the company's performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates activity by a director, which is typical for publicly traded companies.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in financial analysis to gauge sentiment and potential future performance.
- Comparing Weintraub's transactions to those of other directors in similar healthcare technology companies could provide insights into industry trends and company-specific factors.
- Companies like Veeva Systems or Cerner (now Oracle Health) could serve as benchmarks for comparing insider activity and its correlation with stock performance.
Stakeholder Impact
- The acquisition of RSUs by a director can be viewed positively by shareholders as it aligns management's interests with the company's success.
Key Dates
| Date | Description |
|---|---|
| May 10, 2023 | Reporting Person transferred 144,845 shares of Phreesia, Inc. common stock to a grantor retained annuity trust (the 'GRAT') and 6,703 shares of Phreesia, Inc. common stock to an irrevocable trust. |
| June 26, 2024 | Michael Weintraub acquired 8,490 Restricted Stock Units (RSUs). |
| June 26, 2025 | RSUs vest in full, contingent on this date or the next annual meeting of the Issuer's stockholders. |
| June 28, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.